Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness has a significant psychological impact on those affected.

Micro-needling with growth factors and minoxidil improved hair growth in a balding man.

Early-onset male baldness may indicate a higher risk of prostate cancer.

Early baldness in men may indicate a higher risk of prostate cancer.

Female pattern hair loss causes significant hair thinning and affects self-confidence.

Androgenetic alopecia causes hair thinning in women, affecting their quality of life.

Oral minoxidil may help with female hair loss.

Oral Minoxidil could be a safe and effective alternative treatment for various non-androgenic alopecias.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

Certain inflammatory molecules and leptin may contribute to hair loss in cicatricial alopecia.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

Platelet-rich plasma (PRP) injections can effectively increase hair density and thickness in people with androgenic alopecia, without major side effects.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Ketoconazole lotion can improve hair regrowth for some people with androgenetic alopecia.

Estrogen and progesterone don't directly affect hair growth in androgenic alopecia and alopecia areata.

Forsythiaside-A, a natural substance, can protect against hair loss and is more effective than current treatments, potentially making it a good option for hair loss treatment.

Korean red ginseng can significantly increase hair density and thickness in people with androgenic alopecia.

Spironolactone may help reduce hair loss in androgenic alopecia.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Women can also experience hair loss due to hormone changes.

The conclusion is that balancing cost and carbon emissions in hybrid power systems is crucial, especially when high reliability is needed, but the model needs to consider all device efficiencies and distribution losses.

Platelet-Rich Plasma (PRP) is a cheap and promising treatment for hair loss, improving hair count, thickness, and strength without major side effects.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.